Tag: GENETIC-AF
ARCA completes enrolment for GENETIC-AF Phase 2B clinical trial
ARCA biopharma has announced the completion of enrolment for GENETIC-AF. This Phase 2B, double-blind, superiority clinical trial is evaluating bucindolol hydrochloride (Gencaro) as a...
Anders Hove joins Arca Biopharma board of directors
Anders Hove has joined Arca Biopharma’s board of directors.
“Anders brings decades of experience building and advising biopharmaceutical companies,” says Michael R Bristow, president and chief...